SERPINA1 and obesity due to melanocortin 4 receptor deficiency: Moreover, recent clinical studies suggested that SERPINA1 is also a promising anti-inflammatory therapeutic to treat obesity-associated insulin resistance, cystic fibrosis, and COVID-19.44